Clay Alspach

Drug Pricing
Federal Insights and Advocacy Practice Lead

Clay Alspach


[email protected]

Former chief health counsel for the U.S. House of Representatives Energy and Commerce Committee.

Clay Alspach is a principal based in Washington, D.C.  Clay specializes in health care policy and advocacy related to the Food and Drug Administration, health information technology, Medicare Parts B, C, and D, Medicaid, private health insurance, and the Affordable Care Act.

Prior to joining Leavitt Partners, Clay served as Chief Health Counsel for Chairman Fred Upton of the U.S. House of Representatives Energy and Commerce Committee.  During seven years with the committee, he managed, provided strategic direction, and served as the principal representative for the committee on all of its health care-related work. Clay spearheaded legislative initiatives that successfully reformed the SGR (MACRA), reauthorized FDA user fees (FDASIA), and established a national system for drug supply chain security (Drug Quality and Security Act). Clay also led the committee’s legislative accomplishments on biopreparedness and security, public and private medical research, controlled substance and DEA matters, and several other public health initiatives. Most recently, Clay led the committee’s work on the 21st Century Cures Act.

Prior to this service for the committee, Clay clerked for the Honorable Ronald L. Buckwalter of the U.S. District Court for the Eastern District of Pennsylvania and worked as a litigator in private law practice. He also worked as a legislative clerk at the committee from 1999 to 2000 under Chairman Thomas J. Bliley (R-VA).

Clay received his bachelors of arts cum laude from the University of Richmond and holds a juris doctorate from the University of Texas at Austin.